Related Experiment Video

Updated: May 19, 2026

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
05:31

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Published on: January 26, 2024

Competing risks model in early screening for preeclampsia by biophysical and biochemical markers

Ranjit Akolekar1, Argyro Syngelaki, Leona Poon

  • 1Harris Birthright Research Centre of Fetal Medicine, King’s College Hospital, London, UK.

Fetal Diagnosis and Therapy
|August 22, 2012
PubMed

Insights

This study developed a new model for predicting preeclampsia (PE) using first-trimester maternal characteristics and biomarkers. The model effectively screens for early-onset PE, improving prediction accuracy.

Area of Science:

  • Maternal-fetal medicine
  • Biomedical screening
  • Predictive modeling

Background:

  • Preeclampsia (PE) poses significant risks to maternal and fetal health.
  • Early detection of PE is crucial for timely intervention and improved outcomes.
  • Current screening methods have limitations in accuracy and scope.

Purpose of the Study:

  • To develop and validate a predictive model for preeclampsia (PE).
  • To utilize maternal characteristics and first-trimester biophysical and biochemical markers for PE prediction.
  • To treat gestational age at delivery for PE as a continuous variable for enhanced modeling.

Main Methods:

  • A screening study involving singleton pregnancies at 11-13 weeks' gestation.
  • Development of a survival time model incorporating maternal characteristics.
  • Integration of uterine artery pulsatility index (PI), mean arterial pressure (MAP), PAPP-A, and PLGF MoM values using Bayes' theorem.

Main Results:

  • A linear correlation was observed between biomarker MoM values and gestational age at PE delivery.
  • The model detected 96% of PE cases requiring delivery before 34 weeks.
  • A 54% detection rate for all PE cases was achieved at a 10% false-positive rate.

Conclusions:

  • A novel, effective model for first-trimester preeclampsia screening has been developed.
  • The model demonstrates strong predictive performance for early-onset PE.
  • This advancement offers improved early detection capabilities for preeclampsia.
Abstract

More Related Videos

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo12:17

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

Published on: August 2, 2017

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the patient.